(19)
(11) EP 4 267 114 A1

(12)

(43) Date of publication:
01.11.2023 Bulletin 2023/44

(21) Application number: 21840943.1

(22) Date of filing: 21.12.2021
(51) International Patent Classification (IPC): 
A61K 9/51(2006.01)
A61K 47/10(2017.01)
A61P 3/10(2006.01)
A61K 47/18(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/5146; A61K 9/5169; A61P 3/10; A61K 47/10; A61K 47/183
(86) International application number:
PCT/EP2021/087031
(87) International publication number:
WO 2022/136393 (30.06.2022 Gazette 2022/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.12.2020 EP 20383153

(71) Applicant: Universidad de Navarra
31009 Pamplona (Navarra) (ES)

(72) Inventors:
  • GONZÁLEZ NAVARRO, Carlos Javier
    31008 Pamplona, Navarra (ES)
  • IRACHE GARRETA, Juan Manuel
    31008 Pamplona, Navarra (ES)
  • MARTÍNEZ-LÓPEZ, Ana Luisa
    31008 Pamplona, Navarra (ES)
  • REBOREDO FUENTES, Cristian
    31008 Pamplona, Navarra (ES)
  • VIZMANOS PÉREZ, José Luis
    31008 Pamplona, Navarra (ES)

(74) Representative: ABG Intellectual Property Law, S.L. 
Avenida de Burgos, 16D Edificio Euromor
28036 Madrid
28036 Madrid (ES)

   


(54) ZEIN NANOPARTICLES FOR USE IN HYPERGLYCEMIC CONDITIONS